Molecule to Market is proudly sponsored by Bora Pharmaceuticals - The premium CDMO partner

Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 243

    20 years of CPHI – Veterans Guide

    Veterans

    /

    Raman gathers great insider tips from a wise group of veterans of CPHI who have two decades of experience.

  • Episode 242

    Themes from PBOA Conference 2025

    Gil Roth

    / Pharma & Biopharma Outsourcing Association (PBOA)

    Gil Roth, President, at Pharma & Biopharma Outsourcing Association (PBOA) discusses the themes from this year’s PBOA Conference.

  • Episode 241

    The understated CDMO CCO

    Jean-Baptiste

    / Agnus

    JB Agnus, CCO of Bora Pharmaceuticals joins our podcast discussing about the pharmaceutical and biotechnology supply chain.

  • Episode 240

    The CEO driving change at Curia

    Philip Macnabb

    / Curia

    Philip Macnabb, CEO of Curia joins podcast to discuss his private equity experience and navigating the COVID comedown at Curia.

  • Episode 239

    The People-first CEO of FUJIFILM Biotechnologies

    Lars Petersen

    / FUJIFILM Biotechnologies

    Lars Petersen, President & Chief Executive Officer at FUJIFILM Biotechnologies joins the podcast to discuss his transition to the CDMO side.

  • Episode 238

    Driving growth and removing waste for big pharma

    Matt Lowe

    / Performance.io/

    Matt Lowe, Founder and CEO of Performance.io/ discusses seeing a niche in SEO within the healthcare space.

  • Episode 237

    Riding the ups and downs of entrepreneurship

    Michael Scholl

    / Leukocare

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Scholl, Chief Executive Officer and Co-Founder at Leukocare. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Michael, covering: Michael Scholl is the Co-founder and Chief Executive Officer of Leukocare, a …

  • Episode 236

    Unlocking CDMO growth via commercial excellence

    Kaan-Fabian Kekec

    / Simon-Kucher

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kaan-Fabian Kekec, Partner in Healthcare and Life Sciences at Simon-Kucher. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kaan, covering: Kaan leads the firm’s Healthcare B2B and Pharma Services business globally, …

  • Episode 235

    Pharma services market sentiment at the midpoint of 25

    Adam Siebert

    / L.E.K. Consulting

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Siebert, Managing Director and Partner at L.E.K. Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: Adam is a Managing Director and Partner in L.E.K. Consulting’s New York …

  • Episode 234

    Doc to CEO – 40 years of reinvention in biopharma

    Stephen Dilly

    / Codexis

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stephen Dilly, Chairman, President and Chief Executive Officer at Codexis. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Stephen, covering: As President & CEO of Codexis since August 2022, Stephen brings …

  • Load more